75 related articles for article (PubMed ID: 6145937)
21. [Early diagnosis of nasopharyngeal carcinoma using recombinant antigens expressed in bacteria].
Wan Z; Pi G; Sun N
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):74-6. PubMed ID: 12515179
[TBL] [Abstract][Full Text] [Related]
22. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
[TBL] [Abstract][Full Text] [Related]
23. Further studies on antibodies to early antigens induced by Epstein-Barr virus in nasopharyngeal carcinoma patients.
Ida S; Hinuma Y; Chu CT; Chiou JF; Lai JG
Gan; 1973 Dec; 64(6):545-53. PubMed ID: 4360581
[No Abstract] [Full Text] [Related]
24. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
25. [Screening of dominant epitopes of antigens related to antibodies in the sera of patients with nasopharyngeal carcinoma].
Zhang Y; Xiao XB; Zhang CQ; Li JL; Sun Y; Ye YZ; Feng KT
Ai Zheng; 2004 Sep; 23(9):999-1004. PubMed ID: 15363190
[TBL] [Abstract][Full Text] [Related]
26. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
[TBL] [Abstract][Full Text] [Related]
27. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
[TBL] [Abstract][Full Text] [Related]
28. [A prospective study on relationship between abnormal nasopharyngeal mucosa and nasopharyngeal carcinoma].
Huang T; Chen D; Huang H
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):216-8. PubMed ID: 8745460
[TBL] [Abstract][Full Text] [Related]
29. [Expression of the Epstein-Barr virus P150 viral capsid antigen in Escherichia coli for the use as antigen in diagnostic tests].
Fan JA
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):381-7. PubMed ID: 2561513
[TBL] [Abstract][Full Text] [Related]
30. Seroepidemiological studies on nasopharyngeal carcinoma in China.
Zeng Y
Adv Cancer Res; 1985; 44():121-38. PubMed ID: 2994402
[No Abstract] [Full Text] [Related]
31. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
Ling W; Cao SM; Huang QH; Li YH; Deng MQ
Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
[TBL] [Abstract][Full Text] [Related]
32. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
Amador García JM; Mendoza Montero J; Expósito Hernández J; Salinero Hernández J; Esquivias López-Cuerpo J; Ballesteros García P
Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-regulation studies on somatic-cell hybrids derived from the fusion of Burkitt's lymphoma and nasopharyngeal carcinoma cells with human or mouse partners.
Klein G
IARC Sci Publ (1971); 1978; (20):369-76. PubMed ID: 215519
[No Abstract] [Full Text] [Related]
34. [Detection of IgA antibody to EB virus VCA from patients with nasopharyngeal carcinoma by immunofluorescence test (author's transl)].
Zeng Y; Shang M; Liu CR; Cheng YZ; Du RS; Li XZ; Gan BW; Hu MJ; Chen M; He SQ; Mu GP
Zhonghua Zhong Liu Za Zhi; 1979; 1(2):81-3. PubMed ID: 233359
[No Abstract] [Full Text] [Related]
35. Epstein-Barr virus seroepidemiology in China.
Zeng Y; Pi GH; Deng H; Zhang JM; Wang PC; Wolf H; De Thé G
AIDS Res; 1986 Dec; 2 Suppl 1():S7-15. PubMed ID: 3030349
[TBL] [Abstract][Full Text] [Related]
36. A new strain of Epstein-Barr virus derived from nasopharyngeal carcinoma hybrid cells.
Takimoto T; Ogura H; Sato H; Hatano M
Gan; 1984 Nov; 75(11):947-9. PubMed ID: 6097492
[TBL] [Abstract][Full Text] [Related]
37. Frequent allelic loss at the FRA3B site in endemic nasopharyngeal carcinoma: association with clinical features and Epstein-Barr virus infection.
Deng YF; Zhou DN; Lu YD
J Laryngol Otol; 2007 Nov; 121(11):1073-8. PubMed ID: 17359554
[TBL] [Abstract][Full Text] [Related]
38. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma.
Ammatuna P; de Thè G; Speciale R; Sammartano F; Arista S; Zerillo G
Microbiologica; 1988 Apr; 11(2):89-94. PubMed ID: 2841559
[TBL] [Abstract][Full Text] [Related]
39. Liu et al. respond to "Epstein-Barr virus screening for nasopharyngeal carcinoma".
Liu Z; Ye W; Zeng YX; Cao SM
Am J Epidemiol; 2013 Feb; 177(3):254-5. PubMed ID: 23255782
[No Abstract] [Full Text] [Related]
40. [Application of anticomplement immunoenzymatic method for the detection of EBNA in carcinoma cells and normal epithelial cells from nasopharynx (author's transl)].
Zeng Y; Pi GH; Zhang Q; Shen SJ; Zhao ML; Ma JL; Dong HJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Dec; 2(4):220-3. PubMed ID: 6273001
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]